Month: May 2021

SAN CARLOS Calif., May 13, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced financial results for the first quarter ended March 31, 2021, and provided an overview of recent developments. “The first few months of 2021 have been a productive period at Atreca, and we look forward to reporting initial summary data from our Phase 1b trial of ATRC-101 in July of this year,” said John Orwin, Chief Executive Officer. “We are making good progress enrolling the monotherapy cohorts, and are moving quickly to commence the combination cohorts evaluating ATRC-101 with both checkpoint inhibitors targeting the PD-1/PD-L1...

Clinical trials underway with next-generation candidates incorporating PN chemistry Clinical data from PN chemistry programs expected in 2022 In vivo ADAR editing data for AATD program on track for 1H 2021 Wave to host investor conference call and webcast at 8:30 a.m. ET today CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced financial results for the first quarter ended March 31, 2021 and provided a business update. “Despite our PRECISION-HD results at the end of the first quarter, it has been a productive start of the year for Wave and our team remains focused on advancing our clinical trials for ALS/FTD, HD and DMD. These new trials mark the...

KING OF PRUSSIA, Pa., May 13, 2021 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced financial results for its first quarter ended March 31, 2021. “Our strong start to 2021 reflects the trust our customers have in us to help them navigate today’s complex and dynamic commerce landscape. The entire team is laser focused on our mission to enable every business to transact, comply and grow with confidence,” said David DeStefano, Vertex President and Chief Executive Officer. “As tax revenues continue to be a key part of our global economic recovery, the mission-critical role of our solutions to enable growth and reduce tax compliance friction will only continue. The investments we are making in our people and technology keep us well-positioned to...

Do business safer, faster and easier, the way consumers preferDallas, May 13, 2021 (GLOBE NEWSWIRE) — Thryv Holdings, Inc. (NASDAQ:THRY), the provider of Thryv® software, the leading end-to-end customer experience platform built for growing small businesses, today announced it has launched a free ThryvPaySM app designed specifically for service-based businesses.  The app is available for download at no cost on iOS and Android devices, and transforms the way service-based businesses accept and process payments from their customers. Typically handling larger payment amounts, they can now accept safe, contactless payments in just a few simple clicks with unique built-in features that save them significant time and money.  “Our Thryv software is a complete platform for small businesses to operate in, handling more...

– Sol-Gel is in advanced negotiations with a potential partner regarding the commercialization of EPSOLAY® and TWYNEO® – EPSOLAY PDUFA goal date was set for April 26, 2021. Awaiting FDA’s pre-approval inspection – TWYNEO PDUFA goal date set for August 1, 2021 NESS ZIONA, Israel, May 13, 2021 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stagedermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced financial results for the first quarter ended March 31, 2021 and provided corporate updates. Corporate Highlights and Recent DevelopmentsSol-Gel is in advanced negotiations with a potential partner regarding the commercialization of EPSOLAY (benzoyl peroxide, 5%) topical cream and...

WEST FARGO, N.D., May 13, 2021 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today it will release financial results for the first quarter ended April 30, 2021, on Thursday, May 27, 2021, followed by an investor conference call at 7:30 a.m. Central time (8:30 a.m. Eastern time). Investors interested in participating in the live call can dial (877) 705-6003 from the U.S. International callers can dial (201) 493-6725. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, June 10, 2021, by dialing (844) 512-2921 from the U.S., or (412) 317-6671 from international locations, and entering confirmation code 13719598. There also will be a simultaneous, live webcast...

CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced financial results for the first quarter ended March 31, 2021 and provided a corporate update.  “We remain on track to identify the recommended Phase 2 dose for gavo-cel in 2021 and advance into the expansion portion of the Phase 1/2 trial where our primary focus will be efficacy as well as continuing to monitor for safety. The clinical benefit we have observed with our cancer patients gave us confidence to expand our manufacturing capabilities by establishing a commercial-scale cGMP facility in Rockville, Maryland, which we expect to come online in 2023,” said Garry Menzel, Ph.D., President and Chief Executive...

MEMPHIS, Tenn., May 13, 2021 (GLOBE NEWSWIRE) — First Horizon Corporation (NYSE: FHN) today announced that on July 10, 2021 (the “Redemption Date”), it will redeem all outstanding shares of its Non-Cumulative Perpetual Preferred Stock, Series A (the “Series A Preferred Stock”), and all related outstanding depositary shares, each representing a 1/4,000th interest in a share of the Series A Preferred Stock (“the Series A Depositary Shares”) (NYSE: FHN.PR A). After the redemptions, no shares of Series A Preferred Stock, and no Series A Depositary Shares, will remain outstanding. The redemption price will be $25.00 per Series A Depository Share, corresponding to $100,000 per share of Series A Preferred Stock. Accrued dividends will not be included in either redemption price because the Redemption Date is also a dividend...

FORT WORTH, Texas, May 13, 2021 (GLOBE NEWSWIRE) — Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today its financial results for the first quarter ended March 31, 2021.   First Quarter 2021 Highlights and Recent DevelopmentsProduction sales of 1,773 MBoe for the first quarter of 2021, or 19.7 MBoe per day, an increase from 1,720 MBoe, or 18.9 MBoe per day in the prior year quarter, primarily due to new production from the Mid-Con Acquisition and the Silvertip Acquisition (both as defined below) included in part of the first quarter of 2021. Production sales volumes were also within production guidance for the quarter previously given by the Company.Total operating expenses of $27.5 million for the quarter, and operating expenses exclusive of production and ad valorem taxes of $23.9...